相似文献
1
Significance of anti-inflammatory effects of PPARgamma agonists?
Gut. 2006 Aug;55(8):1067-9. doi: 10.1136/gut.2005.089946.
2
[The peroxisome-proliferator-activated gamma receptor and chronic inflammatory bowel disease (PPARgamma and IBD)].
J Soc Biol. 2006;200(2):121-31. doi: 10.1051/jbio:2006015.
3
PPARgamma as a new therapeutic target in inflammatory bowel diseases.
Gut. 2006 Sep;55(9):1341-9. doi: 10.1136/gut.2006.093484.
4
Genomic analysis of sulfasalazine effect in experimental colitis is consistent primarily with the modulation of NF-kappaB but not PPAR-gamma signaling.
Pharmacogenet Genomics. 2009 May;19(5):363-72. doi: 10.1097/FPC.0b013e3283299a73.
5
Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma.
Int Immunopharmacol. 2006 Aug;6(8):1233-42. doi: 10.1016/j.intimp.2006.02.013. Epub 2006 Apr 7.
6
[Anti-inflammatory effect of PPARgamma agonists: basics and clinical applications].
Nihon Rinsho. 2010 Feb;68(2):278-83.
7
5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model.
Clin Cancer Res. 2007 Nov 1;13(21):6527-31. doi: 10.1158/1078-0432.CCR-07-1208.
8
Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis.
J Nutr Biochem. 2012 Sep;23(9):1092-9. doi: 10.1016/j.jnutbio.2011.06.002. Epub 2011 Dec 1.
9
Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
J Physiol Pharmacol. 2011 Jun;62(3):347-56.
10
Comparison of prostaglandin E2 receptor subtype 4 agonist and sulfasalazine in mouse colitis prevention and treatment.
J Pharmacol Exp Ther. 2010 Dec;335(3):546-52. doi: 10.1124/jpet.110.173252. Epub 2010 Sep 10.
引用本文的文献
1
LRG1: an emerging player in disease pathogenesis.
J Biomed Sci. 2022 Jan 21;29(1):6. doi: 10.1186/s12929-022-00790-6.
2
Effect of 6-Benzoyl-benzothiazol-2-one scaffold on the pharmacological profile of α-alkoxyphenylpropionic acid derived PPAR agonists.
J Enzyme Inhib Med Chem. 2020 Dec;35(1):524-538. doi: 10.1080/14756366.2020.1713771.
3
Nitrated oleic acid up-regulates PPARgamma and attenuates experimental inflammatory bowel disease.
Free Radic Biol Med. 2010 Feb 15;48(4):499-505. doi: 10.1016/j.freeradbiomed.2009.11.014. Epub 2009 Nov 20.
4
PPARgamma1 attenuates cytosol to membrane translocation of PKCalpha to desensitize monocytes/macrophages.
J Cell Biol. 2007 Feb 26;176(5):681-94. doi: 10.1083/jcb.200605038.
本文引用的文献
1
Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.
Gut. 2006 Aug;55(8):1104-13. doi: 10.1136/gut.2005.081745. Epub 2006 Mar 17.
2
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors.
Cell. 2005 Sep 9;122(5):707-21. doi: 10.1016/j.cell.2005.06.029.
3
Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands.
BMC Cancer. 2005 May 16;5:46. doi: 10.1186/1471-2407-5-46.
4
Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats.
Biochem Pharmacol. 2005 Jun 15;69(12):1733-44. doi: 10.1016/j.bcp.2005.03.024.
5
Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma.
J Exp Med. 2005 Apr 18;201(8):1205-15. doi: 10.1084/jem.20041948. Epub 2005 Apr 11.
6
The peroxisome proliferator-activated receptor gamma ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin 10 deficiency.
Inflamm Bowel Dis. 2005 Mar;11(3):231-43. doi: 10.1097/01.mib.0000160805.46235.eb.
7
A CLA's act: feeding away inflammation.
Gastroenterology. 2004 Sep;127(3):994-6. doi: 10.1053/j.gastro.2004.07.038.
8
Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease.
Gastroenterology. 2004 Sep;127(3):777-91. doi: 10.1053/j.gastro.2004.06.049.
9
Pioglitazone, a specific ligand of the peroxisome proliferator-activated receptor gamma reduces gastric mucosal injury induced by ischaemia/ reperfusion in rat.
Scand J Gastroenterol. 2003 May;38(5):468-76.
10
PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages.
Proc Natl Acad Sci U S A. 2003 May 27;100(11):6712-7. doi: 10.1073/pnas.1031789100. Epub 2003 May 9.
Zotero 插件